Mio Sugitani-Yamamoto

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.

Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.

Journal: Annals of hematology

Published: August 10, 2021

Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.

Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.

Journal: Cancer medicine

Published: September 13, 2017

Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Journal: International journal of hematology

Published: October 11, 2016

Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody.

Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody.

Journal: Internal medicine (Tokyo, Japan)

Published: August 16, 2016

Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance.

Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance.

Journal: Genes, chromosomes & cancer

Published: March 31, 2015

Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.

Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.

Journal: Cancer research

Published: October 02, 2014

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia.

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia.

Journal: Journal of hematology & oncology

Published: September 02, 2014

Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy.

Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy.

Journal: Annals of hematology

Published: August 06, 2014

FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.

FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.

Journal: Apoptosis : an international journal on programmed cell death

Published: July 16, 2013

Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells.

Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells.

Journal: Leukemia research

Published: May 20, 2013

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis.

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis.

Journal: International journal of hematology

Published: May 11, 2013

Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality.

Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality.

Journal: Leukemia & lymphoma

Published: April 04, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026